| Secondary |
| Crohn's Disease |
34.8% |
| Drug Use For Unknown Indication |
16.5% |
| Product Used For Unknown Indication |
12.9% |
| Colitis Ulcerative |
9.9% |
| Rheumatoid Arthritis |
6.0% |
| Ankylosing Spondylitis |
3.1% |
| Enterocolitis Haemorrhagic |
2.1% |
| Hypertension |
1.9% |
| Autoimmune Hepatitis |
1.7% |
| Renal Transplant |
1.4% |
| Colitis |
1.2% |
| Diverticulum |
1.2% |
| Antisynthetase Syndrome |
1.1% |
| Diabetes Mellitus |
1.1% |
| Osteoporosis |
1.1% |
| Anaemia |
0.9% |
| Cardiac Failure |
0.9% |
| Clostridial Infection |
0.9% |
| Inflammatory Bowel Disease |
0.9% |
| Drug Exposure During Pregnancy |
0.8% |
|
| Intra-uterine Death |
9.8% |
| Stillbirth |
9.8% |
| Pyrexia |
7.7% |
| Neutropenia |
5.6% |
| Squamous Cell Carcinoma |
5.6% |
| Vomiting |
5.6% |
| Osteonecrosis |
4.9% |
| Thrombocytopenia |
4.9% |
| Weight Decreased |
4.9% |
| Cytolytic Hepatitis |
4.2% |
| Hodgkin's Disease |
4.2% |
| Pancytopenia |
4.2% |
| Transaminases Increased |
4.2% |
| Tubulointerstitial Nephritis |
4.2% |
| Drug Exposure During Pregnancy |
3.5% |
| Pulmonary Tuberculosis |
3.5% |
| Sepsis |
3.5% |
| Tuberculosis |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Lung Adenocarcinoma |
2.8% |
|
| Concomitant |
| Crohn's Disease |
40.4% |
| Drug Use For Unknown Indication |
14.4% |
| Product Used For Unknown Indication |
11.8% |
| Colitis Ulcerative |
9.4% |
| Renal Transplant |
4.1% |
| Ankylosing Spondylitis |
3.3% |
| Rheumatoid Arthritis |
2.8% |
| Premedication |
1.8% |
| Hypertension |
1.5% |
| Autoimmune Hepatitis |
1.4% |
| Osteoporosis |
1.4% |
| Multiple Sclerosis |
1.2% |
| Pain |
1.1% |
| Prophylaxis Against Transplant Rejection |
0.9% |
| Systemic Lupus Erythematosus |
0.9% |
| Prophylaxis |
0.9% |
| Colitis |
0.7% |
| Enterocolitis Haemorrhagic |
0.7% |
| Psoriasis |
0.7% |
| Pulmonary Arterial Hypertension |
0.7% |
|
| Pyrexia |
10.7% |
| Thrombocytopenia |
10.1% |
| Tuberculosis |
7.3% |
| Vomiting |
7.3% |
| Weight Increased |
6.7% |
| Sepsis |
5.6% |
| Urticaria |
5.6% |
| Weight Decreased |
4.5% |
| Colon Cancer |
3.9% |
| Myalgia |
3.9% |
| Renal Failure Acute |
3.9% |
| Crohn's Disease |
3.4% |
| Hepatitis |
3.4% |
| Pancytopenia |
3.4% |
| Paraesthesia |
3.4% |
| Pustular Psoriasis |
3.4% |
| Respiratory Failure |
3.4% |
| Systemic Lupus Erythematosus |
3.4% |
| Systemic Lupus Erythematosus Rash |
3.4% |
| Throat Tightness |
3.4% |
|
| Interacting |
| Crohn's Disease |
51.9% |
| Cardiovascular Disorder |
22.2% |
| Pulmonary Fibrosis |
14.8% |
| Cardiac Failure |
7.4% |
| Bronchitis |
3.7% |
|
| Renal Haemorrhage |
30.0% |
| Metastatic Malignant Melanoma |
20.0% |
| Condition Aggravated |
10.0% |
| Drug Interaction |
10.0% |
| Hepatitis C |
10.0% |
| Myelodysplastic Syndrome |
10.0% |
| Rhabdomyolysis |
10.0% |
|
